Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 7, 2000, Pages

  Corless, John A ^a   Warburton, Chris J ^b  

^a WHISTON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO; QUINOLINE DERIVATIVE; TOLUENESULFONIC ACID DERIVATIVE; ZAFIRLUKAST;

BRONCHIECTASIS; CLINICAL TRIAL; HUMAN; REVIEW;

ACETATES; BRONCHIECTASIS; CLINICAL TRIALS; HUMANS; LEUKOTRIENE ANTAGONISTS; PLACEBOS; QUINOLINES; TOSYL COMPOUNDS;

EID: 84921431549     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002174     Document Type: Review

References (2)

1. Mikami M, Llewellyn-Jones CG, Bayley D, Hill SL, Stockley RA. The chemotactic activity of sputum from patients with bronchiectasis. American Journal of Respiratory & Critical Care Medicine 1998;157(3 Pt 1):723-8.
2. Peters-Golden M. Pulmonary diseases other than asthma as potential targets for antileukotriene therapy. Clinical Reviews in Allergy & Immunology 1999;17(1-2):247-60.